UBS Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$61.6M Sell
1,183,819
-1,097,242
-48% -$57.1M 0.01% 1061
2025
Q1
$97.2M Buy
2,281,061
+525,670
+30% +$22.4M 0.02% 759
2024
Q4
$53.6M Buy
1,755,391
+1,394,324
+386% +$42.6M 0.01% 1074
2024
Q3
$8.28M Buy
361,067
+300,623
+497% +$6.9M ﹤0.01% 1825
2024
Q2
$1.75M Sell
60,444
-69,813
-54% -$2.02M ﹤0.01% 2960
2024
Q1
$2.69M Sell
130,257
-20,934
-14% -$432K ﹤0.01% 2723
2023
Q4
$4.09M Buy
151,191
+67,458
+81% +$1.82M ﹤0.01% 2187
2023
Q3
$2.48M Sell
83,733
-27,695
-25% -$821K ﹤0.01% 2386
2023
Q2
$3.99M Buy
111,428
+74,953
+205% +$2.68M ﹤0.01% 2086
2023
Q1
$855K Sell
36,475
-15,066
-29% -$353K ﹤0.01% 3306
2022
Q4
$1.4M Buy
51,541
+39,556
+330% +$1.08M ﹤0.01% 2865
2022
Q3
$645K Sell
11,985
-11,800
-50% -$635K ﹤0.01% 3175
2022
Q2
$960K Sell
23,785
-22,779
-49% -$919K ﹤0.01% 2918
2022
Q1
$3.08M Buy
46,564
+7,233
+18% +$479K ﹤0.01% 2330
2021
Q4
$3.93M Buy
39,331
+12,756
+48% +$1.28M ﹤0.01% 2313
2021
Q3
$3.32M Buy
26,575
+243
+0.9% +$30.4K ﹤0.01% 2371
2021
Q2
$3.27M Sell
26,332
-34,538
-57% -$4.29M ﹤0.01% 2342
2021
Q1
$9.29M Buy
60,870
+8,831
+17% +$1.35M ﹤0.01% 1493
2020
Q4
$6.71M Buy
52,039
+16,317
+46% +$2.1M ﹤0.01% 1627
2020
Q3
$3.99M Sell
35,722
-3,478
-9% -$389K ﹤0.01% 1877
2020
Q2
$3.18M Buy
39,200
+21,170
+117% +$1.72M ﹤0.01% 1929
2020
Q1
$1.26M Sell
18,030
-1,900
-10% -$132K ﹤0.01% 2497
2019
Q4
$1.56M Buy
19,930
+2,589
+15% +$202K ﹤0.01% 2973
2019
Q3
$1.11M Sell
17,341
-3,622
-17% -$231K ﹤0.01% 3124
2019
Q2
$1.81M Buy
20,963
+10,390
+98% +$897K ﹤0.01% 2588
2019
Q1
$811K Buy
10,573
+6,526
+161% +$501K ﹤0.01% 3066
2018
Q4
$152K Buy
+4,047
New +$152K ﹤0.01% 4314